Tag: guardant360
-
Large Guardant Health study backs use of ‘liquid biopsies’
By Julie Steenhuysen CHICAGO (Reuters) – A large study sponsored by privately held Guardant Health Inc of California showed that its Guardant360 liquid biopsy test, which looks at bits of tumor DNA in blood samples, closely mirrored the cancer genes taken from traditional tissue biopsies. The findings, presented on Saturday at the American Society of…
-
Large Guardant Health study backs use of ‘liquid biopsies’
By Julie Steenhuysen CHICAGO (Reuters) – A large study sponsored by privately held Guardant Health Inc of California showed that its Guardant360 liquid biopsy test, which looks at bits of tumor DNA in blood samples, closely mirrored the cancer genes taken from traditional tissue biopsies. The findings, presented on Saturday at the American Society of…
-
Study finds targeted cancer drugs may work in range of tumor types
By Deena Beasley CHICAGO (Reuters) – Early results from a clinical trial of Roche Holding AG cancer drugs released on Saturday suggest some promise in matching treatments based on abnormalities found in a patient's tumor rather than the organ in which the cancer was originally detected. The findings, presented at the annual meeting of the…
-
Study finds targeted cancer drugs may work in range of tumor types
By Deena Beasley CHICAGO (Reuters) – Early results from a clinical trial of Roche Holding AG cancer drugs released on Saturday suggest some promise in matching treatments based on abnormalities found in a patient's tumor rather than the organ in which the cancer was originally detected. The findings, presented at the annual meeting of the…